Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q4 EPS of ($0.64), $0.14 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.